跳至主要内容
临床试验/NCT04122950
NCT04122950终止不适用

Exergaming to Increase Physical Activity in Overweight/Obese Children and Adolescents

Norwegian University of Science and Technology2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
2
主要终点
Daily time physical activity (moderate, vigorous and very vigorous)

研究概览

简要总结

The primary purpose of this study is to examine the effects of regular exergaming for 8 weeks in 24 overweight/obese children and adolescents (10-17 years) on maximal aerobic fitness (VO2max) and physical activity levels measured before and after (8 weeks) intervention period, and in addition at follow-up (12 weeks). We also wish to investigate the effects on markers of cardio metabolic health and body composition, measured at baseline, 8 weeks and 12 weeks follow-up.

Also, the participants gaming frequency will be registered throughout the 8 week period, as well as during the follow-up between 8 and 12 weeks. Aim of this study is to investigate if access to this game can provide health benefits for overweight/obese children and adolescents.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
10 Years 至 24 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Defined as overweight/obese for age and sex
  • Able to ride a bike for up to 60 minutes

排除标准

  • Known cardiovascular disease
  • Taking beta-blockers or anti-arrhythmic drugs
  • Other diseases that restrict them from doing High-Intensity Training

结局指标

主要结局

Daily time physical activity (moderate, vigorous and very vigorous)

时间窗: 12 weeks

Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and at 12 weeks.

次要结局

  • Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)(8 and 12 weeks)
  • Bioelectrical impedance(8 and 12 weeks)
  • Fasting triglycerides, LDL-, HDL- and Total cholesterol, as blood marker of cardiometabolic health(8 and 12 weeks)
  • Daily average energy expenditure(8 and 12 weeks)
  • Daily average number of steps(8 and 12 weeks)
  • Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)(8 and 12 weeks)
  • glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health(8 and 12 weeks)
  • VO2max(8 and 12 weeks)
  • Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)(8 and 12 weeks)
  • Daily average total physical activity duration(8 and 12 weeks)
  • Daily time in vigorous intensity activity(8 and 12 weeks)
  • Blood Pressure(8 and 12 weeks)
  • Fasting circulating glucose, as blood marker of cardiometabolic health(8 and 12 weeks)
  • Circulating insulin concentration, as blood marker of cardiometabolic health(8 and 12 weeks)
  • Daily time physical activity (moderate, vigorous and very vigorous)(8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验